Purchases and Sales Made in Q3 2022 in Dermata Therapeutics, Inc. (DRMA)
This table provides information about the institutional ownership of Dermata Therapeutics, Inc. (DRMA) during Q3 2022. The information is specifically focused on institutions that hold shares of Dermata Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2022
Q3 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
70.8KNew |
$7.08K - $13.9M
|
70.8K
$94.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
23.6KNew |
$2.36K - $4.64M
|
23.6K
$31.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
23.6KNew |
$2.36K - $4.64M
|
23.6K
$31.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
13.4K+ 121.52% |
$1.34K - $2.64M
|
24.4K
$32.7K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
3.59K+ 32.04% |
$359 - $707K
|
14.8K
$19.8K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-22- 0.46% |
$2.2 - $4.33K
|
4.77K
$6.39K
|